Pfizer strikes $5.2bn eczema firm deal

Home › Pfizer strikes $5.2bn eczema firm deal

Drugmaker Pfizer will acquire the maker of a new eczema treatment in a deal worth $5.2bn (3.6bn).

22.11	'Scammers sent courier to steal 4,000'
22.11	Spain fines budget airlines including Ryanair 179m
22.11	Formulating Biphasic and Triphasic Products
22.11	Gatwick terminal evacuated due to security risk
22.11	68% of US households have a smart TV, 46% have a streaming media player
22.11	Reliance and Disney complete India JV transaction
22.11	HbbTV Association appoints Service List Registry
22.11	ocilion brings Prime Video and YouTube to its IPTV platform
Consumer Goods and Services »

je.st